Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2012-07-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study of the C8 MediSensors Optical Glucose Monitor™
NCT01726114
Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions
NCT05144802
Glucose Time-In-Range Development Evaluation
NCT03670017
Performance Study Using the OptiScanner on Healthy Diabetics
NCT01135771
Accuracy of CGM in the ICU, Compared to Standard of Care
NCT04352907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years.
* Admitted to the ICU of Erasme University Hospital.
* Expected ICU stay of ≥ 3 days at the time of enrollment (as judged by the Principle Investigator).
* APACHE II score of ≥ 10, within the first 24 hours of ICU admission.
* Existing central venous catheter + arterial catheter.
* No participation in any other investigational interventional study while enrolled in this study.
* Hyperglycemia (BG \> 150 mg/dl) at the time of admission.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
OptiScan Biomedical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Charles Preiser, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Erasme University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasme University Hospital
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Righy Shinotsuka C, Brasseur A, Fagnoul D, So T, Vincent JL, Preiser JC. Manual versus Automated moNitoring Accuracy of GlucosE II (MANAGE II). Crit Care. 2016 Nov 25;20(1):380. doi: 10.1186/s13054-016-1547-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2001078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.